华润系1400亿中药“舰队”逆势猛增!谁是下个“猎物”?

E药经理人
19 Mar

并购整合打造出千亿市值中药产业航母,华润的下一个优质标的会是谁?会有吗?撰文| Kathy营收增长25.57%、净利上涨35.29%。东阿阿胶开启业绩逆势狂飙。过去一年的中药行业,过得并不轻松。虽处政策红利期,但行业走到了结构调整与转型升级阶段,这也导致了自2024年中开始,中药板块上市公司的业绩开始分化,营收预减、亏损或净利润大幅下降比比皆是。尽管也有企业保持着营收、利润双增,但如东阿阿胶这般...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10